AI and machine learning (ML) are increasingly transforming the field of radiopharmaceutical development, offering new ways to design, optimize, and evaluate these critical compounds. Radiopharmaceuticals, which are used for both diagnostic imaging and targeted therapy, require precise formulation and testing to ensure safety and efficacy. AI and ML technologies can accelerate this process by analyzing vast amounts of complex data, identifying patterns, and making predictions that were previously time-consuming or difficult.Machine learning algorithms, such as deep learning and reinforcement learning, are used to model molecular interactions, predict the behavior of radiopharmaceuticals within the body, and optimize the selection of radioisotopes for specific targeting. AI-driven tools also enable faster drug discovery by simulating and predicting the outcomes of radiopharmaceutical interactions with biological systems, thus reducing the need for extensive trial and error.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9786208418274
Quantité disponible : Plus de 20 disponibles
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. N° de réf. du vendeur I-9786208418274
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9786208418274
Quantité disponible : Plus de 20 disponibles
Vendeur : Ria Christie Collections, Uxbridge, Royaume-Uni
Etat : New. In. N° de réf. du vendeur ria9786208418274_new
Quantité disponible : Plus de 20 disponibles
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 60 pp. Englisch. N° de réf. du vendeur 9786208418274
Quantité disponible : 2 disponible(s)
Vendeur : Books Puddle, New York, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26404115135
Quantité disponible : 4 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand. N° de réf. du vendeur 409071968
Quantité disponible : 4 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. PRINT ON DEMAND. N° de réf. du vendeur 18404115125
Quantité disponible : 4 disponible(s)
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. AI and machine learning (ML) are increasingly transforming the field of radiopharmaceutical development, offering new ways to design, optimize, and evaluate these critical compounds. Radiopharmaceuticals, which are used for both diagnostic imaging and targeted therapy, require precise formulation and testing to ensure safety and efficacy. AI and ML technologies can accelerate this process by analyzing vast amounts of complex data, identifying patterns, and making predictions that were previously time-consuming or difficult.Machine learning algorithms, such as deep learning and reinforcement learning, are used to model molecular interactions, predict the behavior of radiopharmaceuticals within the body, and optimize the selection of radioisotopes for specific targeting. AI-driven tools also enable faster drug discovery by simulating and predicting the outcomes of radiopharmaceutical interactions with biological systems, thus reducing the need for extensive trial and error. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9786208418274
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. Neuware -AI and machine learning (ML) are increasingly transforming the field of radiopharmaceutical development, offering new ways to design, optimize, and evaluate these critical compounds. Radiopharmaceuticals, which are used for both diagnostic imaging and targeted therapy, require precise formulation and testing to ensure safety and efficacy. AI and ML technologies can accelerate this process by analyzing vast amounts of complex data, identifying patterns, and making predictions that were previously time-consuming or difficult.Machine learning algorithms, such as deep learning and reinforcement learning, are used to model molecular interactions, predict the behavior of radiopharmaceuticals within the body, and optimize the selection of radioisotopes for specific targeting. AI-driven tools also enable faster drug discovery by simulating and predicting the outcomes of radiopharmaceutical interactions with biological systems, thus reducing the need for extensive trial and error.Books on Demand GmbH, Überseering 33, 22297 Hamburg 60 pp. Englisch. N° de réf. du vendeur 9786208418274
Quantité disponible : 2 disponible(s)